Skip to content
About
About
People
R&D
Cultivation
Investors
Investor Relations
News and Press
Portfolio
Aureus Santa Marta
Pura H&W
re+PLAY
Rho Phyto
TruneroxTM
Viola
Contact
About
About
People
R&D
Cultivation
Investors
Investor Relations
News and Press
Portfolio
Aureus Santa Marta
Pura H&W
re+PLAY
Rho Phyto
TruneroxTM
Viola
Contact
Instagram
Twitter
Linkedin
Facebook-f
Twitter
Instagram
About
About
People
R&D
Cultivation
Investors
Investor Relations
News and Press
Portfolio
Aureus Santa Marta
Pura H&W
re+PLAY
Rho Phyto
TruneroxTM
Viola
Contact
×
About
About
People
R&D
Cultivation
Investors
Investor Relations
News and Press
Portfolio
Aureus Santa Marta
Pura H&W
re+PLAY
Rho Phyto
TruneroxTM
Viola
Contact
Avicanna Reports Q1 2022 Financial Statement and Management Change
13 May 2022
Avicanna Announces Closing of Strategic Private Placement
9 May 2022
Avicanna Expands RHO PhytoTM Formulary with the Introduction of Cannabigerol (CBG) Products into the Canadian Market
28 April 2022
Avicanna Enters into Exclusive License and Supply Agreement with Major South American Pharmaceutical Company
13 April 2022
Avicanna Expands its Derma-Cosmetics Brand Pura H&W™ into the European Union through a Partnership with Bio-Gate AG
5 April 2022
Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2021
1 April 2022
« Prev
1
2
3
4
5
6
7
Next »